Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and Claudin-5 expressions in experimental cerebral toxocariasis

Parasite Immunology

Volumn 30, Issue 10, 2008, Pages 525-534

  Liao, C W ^a,b   Cho, W L ^a   Kao, T C ^b   Su, K E ^c   Lin, Y H ^b   Fan, C K ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Cerebral toxocariasis; Claudin 5; Glial fibrillary acidic protein; NK 1 receptor; Substance P

Indexed keywords

CLAUDIN 5; EVANS BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CEREBRAL TOXOCARIASIS; CHOROID PLEXUS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LARVAL STAGE; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOCARA CANIS; TOXOCARIASIS; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; EVANS BLUE; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SUBSTANCE P; TIME FACTORS; TOXOCARA CANIS; TOXOCARIASIS;

MUS; TOXOCARA CANIS;

EID: 51549087371     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2008.01048.x     Document Type: Article

References (60)

1. Holland CV Hamilton C. The significance of cerebral toxocariasis. In Holland CV, Smith HV. (eds) : Toxocara, the Enigmatic Parasite Cambridge, UK, CABI, 2006 58 73.
2. Magnaval JF, Galindo V, Glickman LT Clanet M. Human Toxocara infection of the central nervous system and neurological disorders: a case-control study. Parasitology 1997 115 : 537 543.
3. Vidal JE, Sztajnbok J Seguro AC. Eosinophilic meningoencephalitis due to Toxocara canis: case report and review of the literature. Am J Trop Med Hyg 2003 69 : 341 343.
4. Moreira-Silva SF, Rodrigues MG, Pimenta JL, Gomes CP, Freire LH Pereira FE. Toxocariasis of the central nervous system: with report of two cases. Rev Soc Bras Med Trop 2004 37 : 169 174.
5. Bachli H, Minet JC Gratzl O. Cerebral toxocariasis: a possible cause of epileptic seizure in children. Childs Nerv Syst 2004 20 : 468 472.
6. van Horssen J, Bo L, Vos CM, Virtanen I de Vries HE. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol 2005 64 : 722 729.
7. de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ Breimer DD. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997 49 : 143 155.
8. Koto T, Takubo K, Ishida S, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007 170 : 1389 1397.
9. Van Itallie CM & Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006 68 : 403 429.
10. Wolburg H, Wolburg-Buchholz K, Kraus J, et al. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 2003 105 : 586 592.
11. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003 161 : 653 660.
12. Abbott NJ, Ronnback L Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006 7 : 41 53.
13. Lee JD, Tsai LY, Chen CH, Wang JJ, Hsiao JK Yen CM. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop 2006 97 : 204 211.
14. Kim KS. Microbial translocation of the blood-brain barrier. Int J Parasitol 2006 36 : 607 614.
15. van Horssen J, Brink BP, de Vries HE, van der Valk P Bo L. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007 66 : 321 328.
16. Drevets DA Leenen PJ. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect 2000 2 : 1609 1618.
17. Nikolskaia OV, de ALA, Kim YV, et al. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. J Clin Invest 2006 116 : 2739 2747.
18. Toneatto S, Finco O, van der PH, Abrignani S Annunziata P. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 1999 13 : 2343 2348.
19. Nessler S, Stadelmann C, Bittner A, et al. Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist - a putative role for substance P in CNS inflammation. J Neuroimmunol 2006 179 : 1 8.
20. Fan CK, Du Lin YH, WY Su KE. Infectivity and pathogenicity of 14-month-cultured embryonated eggs of Toxocara canis in mice. Vet Parasitol 2003 113 : 145 155.
21. Thumwood CM, Hunt NH, Clark IA Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988 96 : 579 589.
22. Fan CK, Lin YH, Hung CC Su KE. Larval migratory behavior of long-term-maintained Toxocara canis embryonated eggs in mice. Taiwan Vet J 2004 30 : 99 105.
23. Balasingam V, Dickson K, Brade A Yong VW. Astrocyte reactivity in neonatal mice: apparent dependence on the presence of reactive microglia/macrophages. Glia 1996 18 : 11 26.
24. Ueberham U, Ueberham E, Bruckner MK, et al. Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci 2005 22 : 50 64.
25. Hashimoto M, Kanda M, Ikeno K, et al. Oral administration of royal jelly facilitates mRNA expression of glial cell line-derived neurotrophic factor and neurofilament H in the hippocampus of the adult mouse brain. Biosci Biotechnol Biochem 2005 69 : 800 805.
26. Catalani E, Dal Monte M, Gangitano C, et al. Expression of substance P, neurokinin 1 receptors (NK1) and neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knockout mice. Neuroscience 2006 138 : 487 499.
27. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002 58 : 1256 1261.
28. Nicoletti A, Bartoloni A, Sofia V, et al. Epilepsy and toxocariasis: a case-control study in Burundi. Epilepsia 2007 48 : 894 899.
29. Brown HC, Chau TT, Mai NT, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 2000 55 : 104 111.
30. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003 4 : 376 385.
31. Chang YC, Stins MF, McCaffery MJ, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004 72 : 4985 4995.
32. Grab DJ, Nikolskaia O, Kim YV, et al. African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol 2004 90 : 970 979.
33. Cox DM Holland CV. Influence of mouse strain, infective dose and larval burden in the brain on activity in Toxocara-infected mice. J Helminthol 2001 75 : 23 32.
34. Dubinsky P, Havasiova-Reiterova K, Petko B, Hovorka I Tomasovicova O. Role of small mammals in the epidemiology of toxocariasis. Parasitology 1995 110 : 187 193.
35. Seyfert S, Becher A, Ohring R Faulstich A. The permeability of the blood-CSF barrier in hydrocephalus, polyradiculitis, and meningitis. J Neurol 2004 251 : 355 356.
36. Petito CK Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992 32 : 658 666.
37. Bisser S, Lejon V, Preux PM, et al. Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci 2002 193 : 127 135.
38. Dolinsky ZS, Burright RG, Donovick PJ, et al. Behavioural effects of lead and Toxocara canis in mice. Science 1981 213 : 1142 1144.
39. Good B, Holland CV Stafford P. The influence of inoculum size and time post-infection on the number and position of Toxocara canis larvae recovered from the brains of outbred CD1 mice. J Helminthol 2001 75 : 175 181.
40. Summers B, Cypess RH, Dolinsky ZS, Burright RG Donovick PJ. Neuropathological studies of experimental toxocariasis in lead exposed mice. Brain Res Bull 1983 10 : 547 550.
41. Kayes SG Oaks JA. Effect of inoculum size and length of infection on the distribution of Toxocara canis larvae in the mouse. Am J Trop Med Hyg 1976 25 : 573 580.
42. Epe C, Sabel T, Schnieder T Stoye M. The behavior and pathogenicity of Toxocara canis larvae in mice of different strains. Parasitol Res 1994 80 : 691 695.
43. Gottfredsson M Perfect JR. Fungal meningitis. Semin Neurol 2000 20 : 307 322.
44. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993 123 : 1777 1788.
45. Martìn-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998 142 : 117 127.
46. Furuse M, Fujita K, Hiiragi T, Fujimoto K Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998 141 : 1539 1550.
47. Saitou M, Fujimoto K, Doi Y, et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998 141 : 397 408.
48. Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3. a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 2001 154 : 491 497.
49. Tsukita S, Furuse M Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001 2 : 285 293.
50. Morita K, Sasaki H, Furuse M Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999 147 : 185 194.
51. Brooks TA, Ocheltree SM, Seelbach MJ, et al. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res 2006 1120 : 172 182.
52. Kirk J, Plumb J, Mirakhur M McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003 201 : 319 327.
53. Kitajima Y, Endo T, Nagasawa K, et al. Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinol 2006 147 : 694 699.
54. Amasheh S, Schmidt T, Mahn M, et al. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 2005 321 : 89 96.
55. Wang F, Daugherty B, Keise LL, et al. Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 2003 29 : 62 70.
56. Wu Z, Nybom P Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction associated proteins occludin and ZO-1. Cell Microbiol 2000 2 : 11 17.
57. Annunziata P, Cioni C, Toneatto S Paccagnini E. HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS 1998 12 : 2377 2385.
58. Hamilton CM, Brandes S, Holland CV Pinelli E. Cytokine expression in the brains of Toxocara canis-infected mice. Parasite Immunol 2008 DOI:.
59. Jeon HK, Jung NP, Choi IH, Oh YK, Shin HC Gwag BJ. Substance P augments nitric oxide production and gene expression in murine macrophages. Immunopharmacol 1999 41 : 219 226.
60. Liu H, Mazarati AM, Katsumori H, Sankar R Wasterlain CG. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci USA 1999 96 : 5286 5291.